drugset / Trial / NCT03647072
PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy
RandomizedParallel-groupOpen-labelTreatment
Summary
The study is a Comparative Clinical and Biochemical Study Evaluating the effect of Proton Pump I nhibitors versus histamine 2 Receptor antagonists as an adjuvant with chemotherapy in patients with Non-hodgkin Lymphoma.
Timeline
- Start
- 2018-08-01
- Primary completion
- 2027-10
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Famotidine | Other / unclassified | 40 mg | Oral |
| Comparator | Lansoprazole | Other / unclassified | 60 mg | Oral |
| Comparator | Cyclophosphamide | Other / unclassified | — | — |
| Comparator | Doxorubicin | Other / unclassified | — | — |
| Comparator | Prednisolone | Other / unclassified | — | — |
| Comparator | Rituximab | Monoclonal antibody | — | — |
| Comparator | Vincristine | Small molecule | — | — |